Beranda › Kanker Kepala dan Leher
Uji klinis Kanker Kepala dan Leher yang merekrut di AS
146 studi untuk Kanker Kepala dan Leher merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX30 studi
- Boston, MA22 studi
- New York City, NY21 studi
- Nashville, TN21 studi
- St. Louis, MO15 studi
- Dallas, TX12 studi
- Pittsburgh, PA11 studi
- Durham, NC10 studi
- San Antonio, TX10 studi
- Los Angeles, CA10 studi
- Chicago, IL10 studi
- Baltimore, MD10 studi
- Miami, FL10 studi
- Washington, DC10 studi
- Edison, NJ9 studi
- Philadelphia, PA9 studi
- Tampa, FL9 studi
- Cleveland, OH9 studi
- San Francisco, CA9 studi
- Rochester, MN8 studi
- Portland, OR8 studi
- Columbus, OH8 studi
- New Haven, CT8 studi
- Charleston, SC8 studi
- San Diego, CA7 studi
- Baldwin Park, CA7 studi
- New Rochelle, NY6 studi
- Queens, NY6 studi
- Staten Island, NY6 studi
- Arlington, VA6 studi
- Aurora, CO6 studi
- Mountain View, CA6 studi
- Orlando, FL6 studi
- Birmingham, AL5 studi
- Sacramento, CA5 studi
- Newark, NJ5 studi
- Memphis, TN5 studi
- Atlanta, GA5 studi
- Cedar Rapids, IA5 studi
- Salt Lake City, UT5 studi
Berdasarkan negara bagian
- Alabama5 studi
- Arizona4 studi
- Arkansas3 studi
- California31 studi
- Colorado9 studi
- Connecticut10 studi
- Delaware3 studi
- Distrik Columbia5 studi
- Florida24 studi
- Georgia7 studi
- Illinois11 studi
- Iowa5 studi
- Kansas7 studi
- Kentucky5 studi
- Louisiana3 studi
- Maryland15 studi
- Massachusetts24 studi
- Michigan10 studi
- Minnesota10 studi
- Missouri16 studi
- Nebraska4 studi
- New Jersey13 studi
- New Mexico3 studi
- New York29 studi
- North Carolina14 studi
- Ohio19 studi
- Oklahoma6 studi
- Oregon8 studi
- Pennsylvania20 studi
- Rhode Island4 studi
- South Carolina10 studi
- Tennessee23 studi
- Texas42 studi
- Utah7 studi
- Virginia12 studi
- Washington5 studi
- Wisconsin8 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06788990The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06479811Biospecimen Procurement for Head and Neck Disorders
Menerima pesertaStudi observasional
Usia 3 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03429036A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06997068A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07085091Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07848841A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07814248NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
Menerima pesertaStudi observasional
Usia 3 hingga 99 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06303180DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06667427Intratumoral N17350 in Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07339176Continuous Monitoring of Microvascular Anastomoses: An Observational Trial
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07823283Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06736379A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07644585Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06607406A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07020117Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06096038Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06633224Effects of Infusion Timing on Treatment Response in Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07630168Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06722508First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06657222Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.